Yassi Aghazadeh
banner
yassiag.bsky.social
Yassi Aghazadeh
@yassiag.bsky.social
Assistant Professor at IRCM, University of Montréal; Adjunct at McGill University. Stem cells, islets & regenerative medicine for T1D. AghazadehLab.com
She/her. Tiohtiá:ke/Montreal. Opinions are my own.
Proud PI moment at @RéseauThéCell:
🏅 Ying Deng – Best Poster PhD
🏅 Thea Milland – Best Poster MSc
🏅 Giselle de Leon – Best Poster BSc
Representing @ircm.bsky.social , Ying and Thea @umontreal.ca , Giselle @mcgill.ca

Grateful to organizers Kim Santerre and Dr Corinne Hoesli for this meeting!
October 23, 2025 at 9:38 PM
It was great honor to attend and present at @navbo.bsky.social Vascular 2025 meeting. Huge thanks to the organizers for putting this tremendous meeting together. And what a special session focusing on vascularization of organoids and disease on a chip models.
October 23, 2025 at 9:23 PM
Reposted by Yassi Aghazadeh
📢 McGill University is hiring!

The Department of Pharmacology and Therapeutics, with the Meakins-Christie Labs at the RI-MUHC, invites applications for a tenure-track Assistant Professor in Pluripotent Stem Cells in Regenerative Medicine.

Learn more and apply. ➡️ stemcellnetwork.ca/wp-content/u...
September 29, 2025 at 1:35 PM
Interesting and impactful new work by Estall lab: “Here, we identify a novel biological pathway downstream of glucagon that promotes the hepatic lipid accumulation associated with fasting” 👇🏽👇🏽👇🏽
#Glucagon #MASLD #Fasting
September 26, 2025 at 11:59 PM
Reposted by Yassi Aghazadeh
Congratulations to Dr. Côté on his appointment to the Canadian Academy of Health Sciences! This prestigious distinction recognizes his scientific leadership, the excellence of his health research as well as his commitment to collaboration and innovation in health.
🔗 bit.ly/3HGWhX3
August 21, 2025 at 12:02 PM
Reposted by Yassi Aghazadeh
I’m one of the mentors for this year long internship :) Apply if you have interest in writing and Science Communication. There’s opportunity to get some of your pieces in DB @devbiol.bsky.social!

Apply today!!
🚨Only 4 days to apply!!!🚨Join the SDB SciComm Internship! Gain hands-on experience writing stories on the latest developmental biology discoveries🔬Connect with top mentors & earn $500 to attend the SDB Annual Meeting 🎉! 👉 www.sdbonline.org/science_comm... #SciComm #DevBio
August 13, 2025 at 11:39 AM
Very proud to share the first review from the lab with contributions of all lab members. Writing this gave our new lab opportunity to read and discuss many papers and grow as a team. www.frontiersin.org/journals/imm...
www.frontiersin.org
August 4, 2025 at 1:22 PM
Very excited about our project aiming at advancing cell therapies for type 1 diabetes. and very thankful for receiving funding from @stemcellnetwork.ca
June 27, 2025 at 11:13 AM
Reposted by Yassi Aghazadeh
Preza et al. show that a circadian transcription factor specific to maturing stem cell-derived-β cells, DEC1, regulates insulin responsiveness to glucose. 🧪
#PancSky #StemCells

www.biorxiv.org/content/10.1...
DEC1 Regulates Human β Cell Functional Maturation and Circadian Rhythm
Stem cell-derived islet (SC-islet) organoids offer hope for cell replacement therapy in diabetes, but their immature function remains a challenge. Mature islet function requires the β-cell circadian c...
www.biorxiv.org
April 22, 2025 at 8:43 AM
Reposted by Yassi Aghazadeh
Stem cell-based models of early human development

Read this Development at a Glance Article by Lizhong Liu @liliulab.bsky.social and Jun Wu @jun-wu-lab.bsky.social:
journals.biologists.com/dev/article/...
April 22, 2025 at 8:51 AM
Reposted by Yassi Aghazadeh
Bonifacio and Ziegler summarize current evidence and guidance while emphasizing the need for continued research alongside broader screening application in #type1diabetes. 🧪
#PancSky

dom-pubs.onlinelibrary.wiley.com/doi/10.1111/...
Type 1 diabetes risk factors, risk prediction and presymptomatic detection: Evidence and guidance for screening
Type 1 diabetes is recognized as a chronic disease with a presymptomatic phase that does not require insulin therapy and a clinical phase where insulin treatment becomes necessary. The presymptomati...
dom-pubs.onlinelibrary.wiley.com
April 9, 2025 at 9:33 AM
A protective INS SNP causes accelerated IRE1α-dependent decay of insulin mRNA, alleviates ER stress and reduces beta-cell immunogenicity

www.cell.com/cell/fulltex...
Genetic protection from type 1 diabetes resulting from accelerated insulin mRNA decay
Insulin gene variation predisposes individuals to type 1 diabetes (T1D). We report a new mechanism of genetic protection from T1D in which insulin mRNA with a protective SNP is broken down by IRE1α, t...
www.cell.com
March 31, 2025 at 8:23 AM
Reposted by Yassi Aghazadeh
Cdc42 coordinates PDGFRb+ Mural Cell migration proliferation morphogenesis (wrapping filopodia) during postanatal retinal #Angiogenesis👁️

PDGFRb+ mural cell Cdc42 KO🐭➡️
⏫Angiogenic front leakage
⏬Tip cell filopodia
Perturbed arterial patterning

#VasPharma 2025
www.sciencedirect.com/science/arti...
March 26, 2025 at 7:18 AM
Reposted by Yassi Aghazadeh
Nice discussion on the usefulness of genetic and autoantibody screening in children for T1D
March 26, 2025 at 5:20 AM
Happy Persian new year, Norouz, and the beginning of spring! 🌸🪻☀️
March 23, 2025 at 12:05 PM
Reposted by Yassi Aghazadeh
Today, rising stars @drprentice.bsky.social and @yassiag.bsky.social swing through the 🇨🇦 National #Islet and #Diabetes Course to discuss the latest on vascularizing stem cell-derived islet cells, adipose-islet communication, beta cell proliferation, and more @cirtn.bsky.social
a man holding two cell phones with the words kind of a big deal
ALT: a man holding two cell phones with the words kind of a big deal
media.tenor.com
February 19, 2025 at 2:12 PM
Honored to have recieved this together with Dr Hoesli and @martinsauvageau.bsky.social
Au cœur de l’innovation biomédicale au Québec!
L’IRCM félicite ses chercheurs Yasaman Aghazadeh et Martin Sauvageau pour un octroi du réseau ThéCell (Réseau de thérapie cellulaire, tissulaire et génique du Québec) pour un projet structurant en ARN thérapeutique. Avec Corinne Hoesli de McGill U.
February 19, 2025 at 1:50 AM
More cause to celebrate in this anti science climate! Happy international day of women and gender minorities in science 🧬
February 12, 2025 at 12:55 AM
Reposted by Yassi Aghazadeh
Read the latest Special Topic on Endothelial Cell and Pericyte Homeostasis and Pathogenesis in JHC: "Role of the Pancreatic Islet Microvasculature in Health and Disease."

Click to read for FREE: bit.ly/4fihNMw

#capillary #diabetes #endothelialcell
January 27, 2025 at 9:06 PM
Reposted by Yassi Aghazadeh
Still time to apply!

Applications from US welcome – four years can feel longer or shorter depending on where you are 😉
February 2, 2025 at 8:18 PM
Reposted by Yassi Aghazadeh
#RECRUITMENT | Shape Your Future in Biomedical Research
At the IRCM, you can choose the program that best suits you and start your journey towards a rewarding career in research.
The recruitment period runs from December 15, 2024, to January 31, 2025. www.ircm.qc.ca/en/studies
#DrivenByLife
December 19, 2024 at 9:24 PM
Reposted by Yassi Aghazadeh
Application deadline is get closer - make sure you do not miss this exciting EMBO workshop on liver and pancreatic biology and disease 😉

meetings.embo.org/event/25-liv...
Liver and pancreas in metabolic disease: from pathways to therapies
The liver and pancreas arise from a common developmental origin and are controlled by shared gene regulatory programs.These organs are central to two of the most common and devastating metabolic dise…
meetings.embo.org
January 21, 2025 at 9:10 PM
Reposted by Yassi Aghazadeh
Amidst the craziness in the world right now I feel there is even more reason to celebrate:
Xuetao's paper is now online! Check it out : www.cell.com/stem-cell-re...
1/3
Microvessel co-transplantation improves poor remuscularization by hiPSC-cardiomyocytes in a complex disease model of myocardial infarction and type 2 diabetes
In this article, Nunes Vasconcelos and colleagues show that co-delivery of adipose-derived microvessels and hiPSC-cardiomyocytes improves cardiomyocyte survival, graft size, and cardiac function in a ...
www.cell.com
January 29, 2025 at 4:54 PM